跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Jamari 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Jamari 40
Approved
STANDARD
Jamari 40
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
168ee9b357237cbe
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
168ee9b357237cbe
Drug Approval Philippines Name
Jamari 40
Product Name
Jamari 40
Registration Number
DRP-10475-03
Brand Name
Jamari 40
Generic Name
Telmisartan
Dosage Form
Tablet
Dosage Strength
40 mg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises Inc.
Distributor
PhilRx Pharma Inc.
Issuance Date
24 March 2022
Expiry Date
30 September 2026
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
168ee9b357237cbe
Type
Standard
Back to Philippines FDA Approvals